Overview

* Albemarle Q3 net sales of $1.3 bln beat analyst expectations

* Adjusted EPS for Q3 beats consensus, despite net loss

Outlook

* Albemarle expects full-year 2025 results towards higher end of $9/kg scenario ranges

* Company reduces full-year 2025 capital expenditures outlook to ~$600 mln

* Albemarle expects positive free cash flow of $300 to $400 mln for full year 2025

Result Drivers

* VOLUME GROWTH - Energy Storage and Ketjen volumes increased by 8%, contributing to net sales

* COST SAVINGS - Improved fixed cost absorption and ongoing cost savings led to a 7% rise in adjusted EBITDA

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net Beat $1.31 $1.28

sales bln bln (16

Analysts

)

Q3 Beat -$0.19 -$0.78

Adjusted (19

EPS Analysts

)

Q3 EPS -$1.72

Q3 Beat $225.60 $192.94

Adjusted mln mln (17

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 16 "hold" and 3 "sell" or "strong sell"

* The average consensus recommendation for the specialty chemicals peer group is "buy."

* Wall Street's median 12-month price target for Albemarle Corp ( ALB ) is $90.00, about 1.7% above its November 4 closing price of $88.45

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)